Serum PCSK9 was first demonstrated to be associated with cardiovascular disease (CVD) in a 60-year-old population without CVD, and even when established CVD risk variables were modulated, this association persisted (Leander et al., 2016). The gene discussed is PCSK9; the disease is cardiovascular disorder.